Advertisement
Screener

NUTRIBAND INC. (NTRB) EBITDA

NUTRIBAND INC. (NTRB) EBITDA

  • 2026-07-31: Basis Reported; EBITDA (m); Operating income -$890.64K; Depreciation and amortization (m).
  • 2026-04-30: Basis Reported; EBITDA (m); Operating income -$1.25M; Depreciation and amortization (m).
  • 2025-10-31: Basis Reported; EBITDA (m); Operating income -$3.88M; Depreciation and amortization (m).
  • 2025-07-31: Basis Reported; EBITDA (m); Operating income -$2.00M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history
2019-01-31 to 2024-04-30
Data captured

Historical EBITDA

EBITDA 3 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-07-31Reported(m)-$890.64K(m)(m)(m)(m)-$585.00K*(m)$322.19K$750.32K(m)
2026-04-30Reported(m)-$1.25M(m)(m)(m)(m)-$563.10K(m)$247.26K$1.20M(m)
2025-10-31Reported(m)-$3.88M(m)(m)(m)$0.00*-$1.75M*(m)$457.11K$3.49M(m)
2025-07-31Reported(m)-$2.00M(m)(m)(m)$0.00*-$1.31M*(m)$562.55K$1.60M(m)
2025-04-30Reported(m)-$1.41M(m)(m)(m)$5.32K-$1.34M(m)$683.43K$982.05K(m)
2024-10-31Reported-$1.35M*-$1.43M$73.15K*(m)(m)$46.96K*-$1.01M*(m)$880.77K$737.10K(m)
2024-07-31Reported-$1.34M*-$1.41M$69.95K*(m)(m)$38.89K*-$1.54M*(m)$773.98K$737.33K(m)
2024-04-30Reported-$1.82M(m)(m)(m)-445.59%$6.20K-$833.93K(m)$974.53K$1.08M(m)
2024-01-31Reported-$1.24M(m)(m)(m)-235.79%(m)(m)(m)(m)(m)(m)
2023-10-31Reported-$1.66M*-$1.72M$67.87K*(m)(m)$0.00*-$1.06M*$427.84K$551.50K$1.33M(m)
2023-07-31Reported-$748.88K*-$824.19K$75.31K*(m)(m)$0.00*-$995.13K*$566.77K$445.12K$678.74K(m)
2023-04-30Reported-$942,677.00(m)(m)(m)-197.65%$2.62K-$749.86K$401.06K$400.43K$839.73K(m)
2023-01-31Reported-$1.61M(m)(m)(m)-305.01%(m)(m)(m)(m)(m)(m)
2022-10-31Reported-$971.74K*-$1.07M$99.78K*(m)(m)$1.27K*-$520.44K*$528.23K$290.72K$1.05M(m)
2022-07-31Reported-$955.58K*-$1.03M$78.67K*(m)(m)$24.21K*-$908.49K*$394.90K$277.87K$908.17K(m)
2022-04-30Reported-$608,404.00(m)(m)(m)-127.30%$43.80K-$744.26K$401.99K$117.81K$768.55K(m)
2022-01-31Reported-$3.7M(m)(m)(m)-1484.51%(m)(m)(m)(m)(m)(m)
2021-10-31Reported-$1.46M*-$1.54M$79.56K*(m)(m)$1.99K*-$1.21M*$183.04K$161.00K$1.45M(m)
2021-07-31Reported-$402.68K*-$482.24K$79.56K*(m)(m)$10.62K*-$88.53K*$213.74K(m)$481.53K(m)
2021-04-30Reported-$237,802.00(m)(m)(m)-54.86%$38.78K-$279.42K$327.51K(m)$551.94K(m)
2021-01-31Reported-$2.11M(m)(m)(m)-1483.45%(m)(m)(m)(m)(m)(m)
2020-10-31Reported$6.52K*-$40.95K$47.47K*(m)(m)(m)$99.74K*(m)(m)$203.98K(m)
2020-07-31Reported-$207.77K*-$225.82K$18.05K*(m)(m)(m)-$112.14K*(m)(m)$193.33K(m)
2020-04-30Reported-$129,446.00(m)(m)(m)-108.45%(m)-$201.51K(m)(m)$191.92K(m)
2020-01-31Reported-$598,045.00(m)(m)(m)-3054.83%(m)(m)(m)(m)(m)(m)
2019-10-31Reported-$312.53K*-$330.57K$18.05K*(m)(m)(m)-$266.36K*(m)(m)$307.01K(m)
2019-07-31Reported-$431.76K*-$449.61K$17.85K*(m)(m)(m)-$238.01K*(m)(m)$406.57K(m)
2019-04-30Reported-$554,916.00(m)(m)(m)-286.64%(m)-$272.55K(m)(m)$567.96K(m)
2019-01-31Reported-$538,266.00(m)(m)(m)-652.68%(m)(m)(m)(m)(m)(m)
2018-10-31Reported-$429.44K*-$488.62K$59.18K*(m)(m)$0.00*-$439.63K*(m)(m)$445.15K(m)
2018-07-31Reported(m)-$1.88M(m)(m)(m)(m)-$355.50K*(m)(m)$1.88M(m)
2018-04-30Reported(m)-$448.10K(m)(m)(m)(m)-$27.44K(m)(m)$448.10K(m)
2017-10-31Reported-$45.23K*-$107.73K$62.50K*(m)(m)(m)-$22.73K*(m)(m)$87.73K(m)
2017-07-31Reported(m)-$92.96K(m)(m)(m)(m)-$30.65K*(m)(m)$92.96K(m)
2017-04-30Reported(m)-$35.62K(m)(m)(m)(m)-$28.08K(m)(m)$35.62K(m)
2016-10-31Reported(m)-$29.98K(m)(m)(m)(m)-$15.52K*(m)(m)$29.98K(m)
2016-07-31Reported(m)-$35.62K(m)(m)(m)(m)-$45.12K*(m)(m)$35.62K(m)
2016-04-30Reported(m)-$52.08K(m)(m)(m)(m)-$55.20K(m)(m)$52.08K(m)

EBITDA 12 month

DateBasisEBITDAOperating incomeDepreciation and amortizationRevenueEBITDA marginCapital spendingOperating cash flowCost of products and servicesResearch and developmentSelling, general and administrationIncome tax expense / benefit
2026-01-31Reported(m)-$8.32M(m)(m)(m)$5.32K-$5.13M(m)$1.89M$6.99M(m)
2025-01-31Reported(m)-$10.28M(m)(m)(m)$92.04K-$4.63M(m)$3.12M$4.31M(m)
2024-01-31Reported-$4.58M(m)(m)(m)-219.83%$51.76K-$3.53M$1.92M$1.96M$3.77M(m)
2023-01-31Reported-$4.15M(m)(m)(m)-199.31%$79.30K-$2.99M$1.79M$982.23K$3.92M(m)
2022-01-31Reported-$5.8M(m)(m)(m)-491.85%$81.59K-$2.81M$1.18M$411.38K$4.02M(m)
2021-01-31Reported-$2.44M(m)(m)(m)-330.27%(m)-$297.06K(m)(m)$2.91M(m)
2020-01-31Reported-$1.9M(m)(m)(m)-511.88%(m)-$894.47K(m)(m)$1.79M(m)
2019-01-31Reported-$3.29M(m)(m)(m)-1343.02%$4.16K-$1.11M(m)(m)$3.29M(m)
2018-01-31Reported(m)-$2.67M(m)(m)(m)(m)-$92.86K(m)(m)$171.95K(m)
2017-01-31Reported(m)-$151.26K(m)(m)(m)(m)-$147.92K(m)(m)$151.26K(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Conexeu Sciences Inc. (CNXU)United States$0.111B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
Inogen Inc (INGN)United States$0.139B-7.00
MYOMO, INC. (MYO)United States$0.065B-2.85
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
Lifeward Ltd. (LFWD)$0.021B
ENvue Medical, Inc. (FEED)United States$0.011B